Personalized Cardiac Pacing System with Real-time Optimization

Publication ID: 24-11857795_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Personalized Cardiac Pacing System with Real-time Optimization,” Published Technical Disclosure No. 24-11857795_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857795_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,795.

Summary of the Inventive Concept

A next-generation cardiac pacing system that leverages machine learning, artificial intelligence, and real-time data analysis to provide personalized pacing protocols and optimal electrode configurations for individual patients, revolutionizing cardiac care.

Background and Problem Solved

The original patent disclosed a method and apparatus for electrode combination selection, which, while effective, has limitations in terms of adaptability and personalization. The new inventive concept addresses these limitations by integrating advanced technologies to provide real-time optimization and tailored pacing protocols.

Detailed Description of the Inventive Concept

The system comprises a neural network that predicts optimal electrode combinations based on a patient's specific heart anatomy and medical history. The controller adjusts pacing parameters in real-time based on the predicted optimal electrode combinations. The system also includes a sensor to detect changes in heart rhythm and adaptively adjust pacing parameters and electrode configurations. Additionally, the system enables remote optimization through a cloud-based server and remote console, providing real-time feedback and recommendations for optimal pacing parameters and electrode configurations.

Novelty and Inventive Step

The new claims introduce the use of machine learning, artificial intelligence, and real-time data analysis to personalize cardiac pacing, which is a significant departure from the original patent's approach. The integration of these advanced technologies provides a non-obvious and novel solution to the problem of cardiac pacing optimization.

Alternative Embodiments and Variations

Alternative embodiments could include the use of different machine learning algorithms, varying levels of automation in the pacing parameter adjustment, or the integration of additional sensors to detect changes in heart rhythm. Variations could also include different user interfaces for remote optimization or the use of edge computing for real-time data analysis.

Potential Commercial Applications and Market

The personalized cardiac pacing system has significant commercial potential in the medical device industry, particularly in the areas of cardiac care and electrophysiology. The system's ability to provide real-time optimization and tailored pacing protocols could revolutionize cardiac care, improving patient outcomes and reducing healthcare costs.

Field of Art

Cardiac medical devices, specifically implantable cardiac stimulation systems with electrode configuration selection and optimization techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with expertise in cardiac electrophysiology, electrical engineering, signal processing, and medical device design, holding at least a master's degree with 3-5 years of experience in cardiac device development

Obviousness Rationale

A PHOSITA would recognize that applying machine learning and adaptive algorithms to electrode configuration selection is a natural progression from the source patent's existing electrode selection methodology. The core technical problem of optimizing cardiac pacing remains consistent, with machine learning providing an enhanced computational approach to solving the same fundamental challenge of selecting optimal electrode configurations. The source patent's framework of electrode configuration selection provides a clear foundation for introducing more sophisticated selection techniques.

Obvious Combinations & Variations

Source Patent Element
Control logic for selecting electrode configurations for cardiac pacing stimuli
PTD Variation
Neural network-based prediction of optimal electrode combinations using patient-specific data
Obviousness Reasoning
Predictable application of machine learning to existing electrode selection methodology, representing an obvious enhancement of known techniques in medical device optimization
Source Patent Element
Determining phrenic nerve activation thresholds for different electrode configurations
PTD Variation
Real-time adaptive adjustment of pacing parameters based on detected heart rhythm changes
Obviousness Reasoning
Known technique of threshold detection extended to dynamic parameter modification, representing a logical progression in cardiac device control strategies
Source Patent Element
User interface for selecting and configuring electrode combinations
PTD Variation
Cloud-based remote optimization system with real-time feedback and recommendations
Obviousness Reasoning
Predictable evolution of user interaction methods, leveraging standard telecommunications and cloud computing technologies to enhance medical device functionality
Source Patent Element
Cardiac pacing system with configurable electrode selections
PTD Variation
Artificial intelligence analysis of patient medical history to generate personalized pacing protocols
Obviousness Reasoning
Obvious application of data-driven personalization techniques to existing medical device optimization frameworks
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857795, the claimed variations in cardiac pacing system design represent obvious extensions of prior art, wherein a person having ordinary skill in the art would readily recognize the application of machine learning, artificial intelligence, and adaptive optimization techniques as predictable improvements to existing electrode configuration selection methodologies.

Original Patent Information

Patent NumberUS 11,857,795
TitleMethod and apparatus to perform electrode combination selection
Assignee(s)Cardiac Pacemakers, Inc.